Source: Eur Respir Rev, 28 (151) 180093; 10.1183/16000617.0093-2018
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
Marie Bruyneel. Telemedicine in the diagnosis and treatment of sleep apnoea. Eur Respir Rev, 28 (151) 180093; 10.1183/16000617.0093-2018

Member's Comments

No comment yet.

Related content which might interest you: Clinical assessment of obstructive sleep apnoea Source: Annual Congress 2006 - PG9 - Obstructive sleep apnoea: current pathophysiological, clinical and therapeutic concepts Year: 2006 Atypical patterns in portable monitoring for sleep apnoea: features of nocturnal epilepsy? Source: Eur Respir J 2013; 41: 368-375 Year: 2013 Empirical Auto-CPAP therapy for diagnosis of sleep apnoea syndrome Source: Eur Respir J 2001; 18: Suppl. 33, 417s Year: 2001 Targeted hypoglossal neurostimulation for obstructive sleep apnoea: a 1-year pilot study Source: Eur Respir J 2013; 41: 360-367 Year: 2013 Treatment of paediatric sleep apnoea Source: Annual Congress 2011 - PG15 Treatment of obstructive sleep apnoea Year: 2011 Personalised medicine in sleep respiratory disorders: focus on obstructive sleep apnoea diagnosis and treatment Source: Eur Respir Rev, 26 (146) 170069; 10.1183/16000617.0069-2017 Year: 2017 Clinical utility of ApneaLink for the diagnosis of sleep apnea in the home setting Source: Annual Congress 2008 - Diagnostic aspects of sleep apnoea Year: 2008 Resources and delays in the diagnosis of sleep apnea and hypopnea syndrome Source: Eur Respir J 2007; 30: Suppl. 51, 329s Year: 2007 Diagnostic efficacy of the KaLinix® intelligent medical device for diagnosis of obstructive sleep apnea and hypopnea syndrome. Source: Virtual Congress 2020 – Screening methods and diagnostic tools for obstructive sleep apnoea Year: 2020 Sleep apnoea - management and therapies Source: International Congress 2018 – PG7 Sleep-disordered breathing - diagnosis and therapy Year: 2018 Age at diagnosis is not related to CPAP use over the first year when treating obstructive sleep apnoea Source: Eur Respir J 2006; 28: Suppl. 50, 410s Year: 2006 Outcome with CPAP in patients with suspected sleep apnea syndrome Source: Annual Congress 2007 - Sleep apnoea Year: 2007 From the laboratory to the bedside: the pharmacotherapy of obstructive sleep apnoea Source: Sleep and Breathing Conference 2021 Year: 2021 Performance assessment of a novel medical device for home monitoring of CPAP treatment in patients with obstructive sleep apnoea syndrome Source: Annual Congress 2013 –Twist in the tale: treating sleep disordered breathing - new technologies, new techniques Year: 2013 Compliance in sleep apnoea therapy: influence of home care support and pressure mode Source: Eur Respir J 2009; 33: 804-811 Year: 2009 Telemedicine(TM)-based strategy for management of obstructive sleep apnea (OSA): Virtual sleep unit Source: International Congress 2018 – New diagnostic tools for sleep and breathing and healthcare provision options Year: 2018 Diagnosis of obstructive sleep apnoea in children: standards for sleep study duration Source: International Congress 2019 – New developments in sleep-disordered breathing, gas exchange and lung function in children Year: 2019 A comparison of laboratory polysomnography and a home sleep study in the diagnosis of obstructive sleep apnea syndrome (OSAS) Source: Annual Congress 2010 - Screening for sleep-disordered breathing Year: 2010 The importance of sleep position in treatment planning of patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Assessment of sleep apnoea Year: 2008 Ato-oxy as the first successful pharmacotherapy for obstructive sleep apnoea Source: International Congress 2019 – New horizons for pharmacotherapy of sleep-disordered breathing: from bench to bedside Year: 2019